Morale has dipped during Covid-19. We’re separated from our friends, families, and colleagues but busier than ever.

Real-world, face-to-face communication—complete with eye contact, body language, and other important sources of information—is a rarity in business today, and the potential for failing to convey an intended message or giving the wrong impression has grown.

Are the days of standard industrial robots numbered? Absolutely not. In part one of this series, we looked at the unique attribute of cobots.

Safety managers have a multitude of safety strategies to protect the health and safety of their workforce. Guidelines for personal protective equipment (PPE), lockout/tagout (LOTO) programs, fire exit signage—the list is endless.

As commercialization strategies evolve amid Covid-19, and supply chains continue to trend toward diversification, the only way for businesses to control their destiny is to double down on quality standards.

The U.S. Department of Defense and more than 80 companies, universities, states, and research institutes will invest at least $275 million during the next seven years to scale up the microbial production of biomolecules.

For conventional, profit-seeking companies, moving into social impact carries huge contradictions.

Any company that decides to enter the mattress business is no doubt entranced by one undeniable fact: Everybody needs one.

Does the phrase “garbage in—garbage out” (GIGO) ring a bell? That’s the idea that if you use flawed, low-quality information to inform your decisions and actions, you’ll end up with a rubbish outcome.

The medical device industry is one that requires preparation. Unlike less regulated industries, there’s an expectation in the industry around the possibility that an inspector or auditor can show up without notice and stop a business in its tracks.